Page last updated: 2024-10-26

valproic acid and Cerebral Cholesterinosis

valproic acid has been researched along with Cerebral Cholesterinosis in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
"Cerebrotendinous xanthomatosis is one of the rare forms of treatable hereditary neurodegenerative disorders."1.35Cerebrotendinous xanthomatosis: a treatable neurodegenerative disease. ( Jayakrishnan, C; Sadanan, S; Sandeep, P; Sreekumar, S; Thulasidharan, NK, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sandeep, P1
Jayakrishnan, C1
Sadanan, S1
Sreekumar, S1
Thulasidharan, NK1

Other Studies

1 other study available for valproic acid and Cerebral Cholesterinosis

ArticleYear
Cerebrotendinous xanthomatosis: a treatable neurodegenerative disease.
    The Journal of the Association of Physicians of India, 2009, Volume: 57

    Topics: Adult; Anticonvulsants; Carbamazepine; Chenodeoxycholic Acid; GABA Agents; Gastrointestinal Agents;

2009